BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  ESBATech’s Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity

  January 9, 2009

   · 

  5 min read
• Deals

  Sunquest Information Systems Adds On

  January 9, 2009

   · 

  1 min read
• Biotech Beach

  Orth-Align Raises $7.2 Million

  January 9, 2009

   · 

  1 min read
• Policy

  WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD

  January 9, 2009

   · 

  2 min read
• Policy

  Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action

  January 9, 2009

   · 

  3 min read
• Policy

  GlaxoSmithKline and XenoPort, Inc. Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome

  January 9, 2009

   · 

  3 min read
• Pharm Country

  Celgene Corporation to Present at the 27th Annual JPMorgan Healthcare Conference

  January 9, 2009

   · 

  1 min read
• BioMidwest

  Emergent BioSolutions Recognized by Security Magazine Among Best Security Organizations

  January 9, 2009

   · 

  1 min read
• Business

  BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering

  January 9, 2009

   · 

  3 min read
• Biotech Bay

  NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Issued Key Composition of Matter Patent for Aganocide(R) Compounds

  January 9, 2009

   · 

  1 min read